Advertisement

Topics

Biolipox AB Company Profile

14:26 EST 9th December 2018 | BioPortfolio

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewarded with the Nobel Prize in 1982. One of the prize winners, Professor Bengt Samuelsson, is currently a member of the Board of Biolipox.

Arachidonic acid is an endogenous substance that through transformation to prostaglandins and leukotrienes regulates a number of inflammatory processes in the body. Biolipox's discovery of a new family - eoxins - formed from the transformation of arachidonic acid, marked the beginning of the company's research on an entirely new class of anti-inflammatory drugs.

Biolipox was founded in June, 2000 and has since then evolved into a research-intensive pharmaceutical company, today counting four full drug development projects in both pre-clinical and clinical phases. One of the projects is aimed at developing a new pain-relieving medication, with a completely new mechanism of action, for the treatment of arthritis patients.

The market for Biolipox's priority research areas was in 2003 USD 40bn (1, 2). These are among today's fastest growing therapeutic areas

Location

Berzelius väg 3, plan 5
Solna
SE-171 65
Sweden

Contact

Phone: 46 8 524 83 100
Email: peter.hein@biolipox.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, c...

Biolipox AB

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, c...

More Information about "Biolipox AB" on BioPortfolio

We have published hundreds of Biolipox AB news stories on BioPortfolio along with dozens of Biolipox AB Clinical Trials and PubMed Articles about Biolipox AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biolipox AB Companies in our database. You can also find out about relevant Biolipox AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record